EMR Documentation Templates
EMR Documentation Templates
NEURO: sensation is intact and equal in the extremities bilaterally. Normal and equal reflexes throught.
MSK:
General Exam
CV: intact and equal pulses in the extremities bilaterally. Normal S1/S2, no m/r/g
NEURO: sensation is intact and equal in the extremities bilaterally. Normal and equal reflexes through
out.
Knee Exam
special testing performed bilaterally and found to be within normal limits including McMurray's,
Lachman's, Varus/Valgus stress testing, ant/post drawer testing, and Apley's testing.
Shoulder Exam
shoulder exam within normal limits including empty can, full can, dropping sign, Hawkins/Kennedy,
Neer's, as well as Obrien's test.
Clearance
Concussion Normal
URI Plan
Patient educated on importance of being aware of symptoms related to sickle cell related illness including
sickle cell crises:
- educated on stopping physical activity and seek medical attention immediately if any of these symptoms
arise
- educated on importance of maintaining good fluid hydration as well as relation to heat illness
- patient is aware of the above and acknowledges receipt of educational material along with todays visit.
Procedure: Patient had guasha performed with Eucrin cream after identifying injured muscle group.
Patient had accupuncture needles placed. She had TENS unit attched and adjusted to tolerable level.
Patient had heat lamp applied and placed for treatment for 15 minutes with no complications.
Visco Documentation
Patient had xray and steroid injection at Emerge Ortho 12 weeks ago with minimal improvement. Records
from that office visit have been reviewed. Severe medial compartment arthritis, mild lateral and moderate
patellofemoral arthritis was noted.
- He has been performing HEP to work on knee strengthening.
- He has been working on weight loss
- continue with Aleve prn.
Patient has symptomatic arthritis of the knee that is affecting activities of daily living. The patient has had
inadequate response, contraindicatoin per FDA label, documented intolerance, or is not a candidate for:
- exercise, weight loss, physical therapy
-NSAIDs
- analgesics
- intra-articular corticosteroid injection.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Left Supra-patellar space was identified. The injection site was marked
and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 4 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 3" needle under Ultrasound Guidance using a Left Lateral
Suprapatellar approach. Patient tolereated the procedure well with minimal bleeding. The injection site
was bandaged and there were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
1 week to re-evaluate, sooner if symptoms worsen. Patient was instructed to call if she experienced any
problems before then and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the muscle tendon junction of the Right Biceps Tendon. This area was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The three marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 2" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the tendon sheath.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
PRP Procedure Note
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the insertion of the Left Achilles Tendon. This area was marked and
prepped using sterile technique with Hibaclence and 70% Isopropyl Alcohol x 3.
The five marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximately 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 1" needle and a total of 4cc of concentrated PRP. Approximately 0.5-1 cc of
PRP was used for each injection along the tendon attachment.
There was minimal bleeding. Area was bandaged with tefla padding and adhesive. There were no
obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on for the
remainder of the day and follow up if there are signs of infection, continued bleeding, or any other
concerning problems. Patient placed in Cam Walker for 2 weeks while wt. bearing. Patient agreed to
the plan and is to follow up in 2 weeks to re-evaluate. Patient was instructed to avoid anti-
inflammatories and use Tylenol for pain as needed. Patient is to avoid painful activity. No lower limb
stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Area of abcess (~2 cm x 1 cm) was prepped in sterile manner with Hibaclense and Etoh x 3. An #11
blade scapel was used to make a 1cm incision along the middle third of the abcess. Drainage was
expressed and sample was obtained for C&S. Further serosanguinous discharge was expressed. Patient
tolereated the procedure well with minimal bleeding. Area was bandaged with tefla pad and cobane.
Patient was told to keep bandage on for the remainder of the day and follow up if there are signs of
increased infection or continued bleeding. Patient agreed to the plan and is to follow up in 4-5 days to
re-evaluate, sooner if symptoms worsen.
Examination revealed minimal swelling of the Left Leg. Casting stocking was cut to the appropriate
length and rolled onto the injured leg. 3" Cast padding was added with reinforcement padding placed.
3" Synthetic casting was added and allowed to set for ~5 minutes while hand molded. Pt reported the
cast was comfortable and questions were answered. Cast care handout was given and follow up x-ray
was arranged to evaluate alignment post-casting.
Epicondylitis Plan
Gastritis Plan
- Pt did not want Promethazine at this time, felt symptoms were improving.
- Bland Diet
- Increase Fluids (1/2 Body Wt in Fluid oz per day) and Electrolytes
- Increase Rest
- Follow up 3-5 days if not improving, sooner if symptoms worsen.
Herpes Plan
Area was prepped in sterile manner with Hibaclense and Etoh x 3. A #10 blade was used to pare callous
skin. 3 treatments of cryotherapy were completed using a cryo pen. Patient tolerated the procedure well
with minimal bleeding. Suggested Salicylic Acid treatment QHS between cryotherapy. Patient agreed to
the plan and is to follow up in 1 week to re-evaluate, sooner if symptoms worsen. Re-evaluate, sooner if
symptoms worsen.
Sinusitis Plan
- Increase Rest
- Zpak
- Tylenol PRN Fever/Pain
- OTC Decongestant prn congestion
- Follow up 5-7 days if not improving, sooner if symptoms worsen.
Laceration is healing well with good approximation of the wound edges and granulation tissue growth.
There are no signs of secondary infection at this time. Patient has minimal pain at the site of injury. A
total of 1 suture was removed without bleeding or separation. Patient tolerated the procedure well.
Discussed signs of secondary infection and reasons to follow up, along with wound care.
URI Plan
- Increase Rest
- Tylenol PRN Fever/Pain
- OTC Decongestant prn congestion
- Follow up 5-7 days if not improving, sooner if symptoms worsen.
Date: 8/14/13
History:Right Knee Pain x 1 month. Pt reports constant knee pain for the last month. Denies any specific
trauma. Denies any history of previous trauma, fever, chills, or night sweats. Able to wt bear without
difficulty. Wearing neoprene knee brace for comfort.
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There was
medium joint effusion noted in the R suprepatellar recess.
LCL, MCL, Quadriceps tendon, and Patella tendon appear intact. No evidence of a popliteal cyst and
hamstring insertion appears normal. Recommend xray/MRI for further evaluation of meniscus with MCL
involvement.
UTI Plan
Hamstring Stain Plan and Dry Needling with PENS Treatment Procedure Note
Questions were answered in regards to treatment with PENS acupuncture and patient is interested in
moving ahead with the procedure at this time (see procedure note below).
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain and muscle tightness was localized to the lateral and medial distal attachment of the Left
Hamstring. A PENS treatment was placed using (8) sterile 60 mm acupuncture needles at the
attachment sites of the Left Hamstring. E-stim was applied using 4 Hz and 30 Hz respectively and left
on for 15 min. A heat lamp was positioned for comfort. Pt tolerated the procedure well. Patient was
instructed to increase hydration and rest over the next 24 hours. Patient is to avoid painful activity.
Patient agreed to the follow up in 1 week, sooner if symptoms worsen.
- Questions were answered in regards to treatment with acupuncture and patient is interested in moving
- Questions were answered in regards to treatment with acupuncture and patient is interested in moving
ahead with the procedure at this time (see procedure note below).
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the Left SCM and Upper Trapezius. Indirect treatment of the upper back
and neck was treated with OMM and Gua Sha. 11 40mm acupuncture needles were placed along
palpable tender points of the Upper Trapezius and SCM, and left in for 15 min. Pt tolerated the
procedure well. Patient was instructed to increase hydration and rest over the next 24 hours. Patient is
to avoid painful activity. Patient agreed to the follow up in 1 week, sooner if symptoms worsen.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Left anterior lateral cyst measuring ~ 2 cm x 2 cm in diameter was
visualized under Ultrasound. The aspiration/injection site was marked and prepped using sterile technique
with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then aspirated with ~ 2cc of
serosanquinous fluid and then injected using the same 18G 1" needle with 2cc of the Corticosteroid
Solution.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Area of hematoma was prepped in sterile manner with Hibaclense and Etoh x 3. An 18G 1" needle with
10 cc Syringe was used to drain hematoma ~ 1.5 cc. Patient tolereated the procedure well with minimal
bleeding. Area was packed and pressure bandage was place on head. Patient was told to keep bandage
on for 3 days and follow up if there are signs of infection or continued bleeding. Patient agreed to the
plan and is to follow up in 1 week to re-evaluate, sooner if symptoms worsen.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the Left SCM and Upper Trapezius. Indirect treatment of the upper back
and neck was treated with OMM and Gua Sha. 14 40mm acupuncture needles were placed along
palpable tender points of the Upper Trapezius using the Cervical PENS protocol of C2/C5, T2/T4, T8/T10,
and GB 21, and left in for 15 min with e-stim at 4Hz and 15 Hz. Pt tolerated the procedure well. Patient
was instructed to increase hydration and rest over the next 24 hours. Patient is to avoid painfull activity.
Patient agreed to the follow up in 4-5 days, sooner if symptoms worsen.
Concussion Plan
- Impact reviewed.
- Physical exam including balance and memory testing appropriate.
- Discussed with trainer, completed RTP protocol without symptoms.
- Pt cleared for full RTP, f/u if symptoms return.
Conjunctivitis Plan
- Keep hands clean and away from eyes
- Clean contact solutions and dispose of old contacts.
- Glasses until symptoms resolve
- Tobradex for up to 1 day after symptoms resolve
- Follow up 2-3 days if not improving, sooner if symptoms worsen.
Verbal consent was obtained from parent and patient, and risks/benefits were explained. Area was
prepped in sterile manner with Povidine and Etoh x 3. 1% lidocaine was injected with 27G 1/2" needle ~
1cc into area of the lesion. A #11 blade was used to make a 5mm incision along the location of the
foreign body. Straight sterile tweezers were used to excise the foreign body, small black object 1mm in
diameter, further exploration revealed no other objects. Area was cleaned and laceration was closed with
one steri strip. Area was covered. Patient to keep clean and covered, follow up if not improving in 2-3
days. Signs of bleeding and secondary infection were explained.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Area of cyst (~ 1 cm in diameter) was prepped in sterile manner with Hibaclense and Etoh x 3. An 25G 1
inch needle was used to aspirate the cyst which minimal fluid was obtained < 1cc. The syringe was
changed and ~ 1cc of a 1:1 mixture of 1% Lidocaine and Kenalog 40 mg was injected into the ares of
the cyst. Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla pad
and cobane. Patient was told to keep bandage on for the remainder of the day and follow up if there are
signs of increased infection or continued bleeding. Patient agreed to the plan and is to follow up in 7
days to re-evaluate, sooner if symptoms worsen.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then injected using a 25G 3" needle
with 2cc of the Orthovisc Product. Patient tolereated the procedure well with minimal bleeding. The
injection site was bandaged and there were no obvious neuro or vascular deficits after the procedure.
Patient was told to keep the bandage on for the remainder of the day and follow up if there are signs of
infection, continued bleeding, or any other concerning problems. Patient agreed to the plan and is to
follow up in 4 weeks to re-evaluate, sooner if symptoms worsen. Patient was instructed to
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain and muscle tightness was localized to the low back R>L. A Lumbar PENS was placed using
(10) sterile 40 mm acupuncture needles at the L2 and L4 Spinal levels, S2 and S4, PSIS, and (2) sterile
60 mm acupuncture needles were place at functional Bladder points 54 bilaterally. E-stim was applied
using 4 Hz and 30 Hz respectively and left on for 15 min. A heat lamp was positioned for comfort. Pt
tolerated the procedure well. Patient was instructed to increase hydration and rest over the next 24
hours. Patient is to avoid painfull activity. Patient agreed to the follow up in 1 week, sooner if symptoms
worsen.
Began with cervical traction followed by ME to the cervical spine as patient was restricted in R ROM. ME
was applied to the back and along with HVLA to the thoracic spione T4-T7. Lower limb adductors and
abductors were treated with ME , followed by sacral rocking and HVLA to L3-L5 Region. Gua Sha was
completed to the Left SI/Glut. Pt tolerated OMM well. Asked to rest over next 24 hours and then resume
normal activities.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the insertion of the Right LCL and lateral patella retinaculum.L. These areas
were marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The 16 marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. A 15% dextrose prolotherapy solution was
used. The sites were then injected using a 25G 2" needle and a total of 15 cc. Approximatley 0.5-1 cc of
PRP was used for each injection along the ligament/tendon enthesis.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the Right PSIS and attachments of the Posterior Sacral Iliac Ligament
complex (Hackett's points A,B,and C), which was marked and prepped using sterile technique with
Hibaclence and 70% Isopropyl Alchohol x 3.
The four marked areas along the attachment of the Right Sacral Iliac Ligaments Enthesis were first
anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium Bicarbonate solution
on a 27G 0.5 inch needle. The sites were then injected using a 25G 2" needle and 15% Dextrose
Solution with ~ 1-2 cc of solution for each injection along the ligament enthesis. Patient tolereated the
procedure well with minimal bleeding. Area was bandaged with tefla padding and adhesive. There were
no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on for
the remainder of the day and follow up if there are signs of infection, continued bleeding, or any other
concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks to re-evaluate.
Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed. Patient is to
avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation. Remain in the
back brace during active back movement.
- Questions were answered in regards to treatment with prolotherapy and patient is interested in moving
ahead with the procedure at this time (see procedure note below).
The area of pain was localized to the Right and Left Anterior/Medial Tibia, which was marked and
prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3. The 5 marked areas
on the Left leg and 6 on the Right along the anterior medial tibia were injected using a 27G 1" needle
and 15% Dextrose Solution with ~ 1-2 cc of solution for each injection along the ligament enthesis.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 2 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Plantar Fascia. These areas were marked and prepped
using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The three marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 1" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the ligament enthesis.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Diagnostic ultrasound was performed in the sagittal and transverse planes on the plantar
aspect of XYZ. Results of diagnostic ultrasound were compared to that of a control, the
plantar fascia of the examiner, Dr. [insert your name here].
Vertical thickness of the plantar fascia was measured in the sagittal and transverse plane
and recorded at XYZ millimeters in thickness inferior to the calcaneal tuberosity, XYZ
millimeters in thickness at the distal end of the calcaneal tuberosity, and XYZ millimeters in
thickness 1.5 - 2cm distal to the leading edge of the calcaneal tuberosity in the patient.
This is in contrast to the control, which was measured and recorded at XYZ mm, XYZ mm,
and XYZ mm, respectively.
OPT/ALT: A significant amount of subcutaneous edema and hyperechoic signal within the
substance of the plantar fascia was noted, in contrast to that of the control, which showed
the control's plantar fascia substance to have a signal intensity isoechoic with tendon and
connective tissue.
OPT/ALT: The plantar fascia was inspected from its insertion on the calcaneal tuberosity in
the medial, central, and lateral bands, extending into the medial arch approximately XYZ
cm, and no evidence of plantar fascia rupture was noted.
OPT/ALT: Range of motion of the metatarsal phalangeal joints was performed during
simultaneous observations of the insertion of the plantar fascia on the medial, central, and
lateral bands.
OPT/ALT: Inspection of the entire plantar fascia, encompassing all three bands from
calcaneal origin throughout the medial arch was performed, and no evidence of plantar
fascia rupture or disruption was noted at the insertion or throughout the substance of the
plantar fascia on all three bands.
OPT/ALT: Palpation of the insertion of the medial and central bands of the plantar fascia
was performed with direct ultrasonic visualization of areas of discomfort during this
examination, confirming insertional plantar fasciitis of the medial and central bands of the
plantar fascia.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the insertion of the Right Peroneus Brevis Tendon, Dorsal Calcaneocuboid
Ligament, and Bifurcate Ligament. These areas were marked and prepped using sterile technique with
Hibaclence and 70% Isopropyl Alchohol x 3.
The three marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 1" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the ligament/tendon enthesis.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the insertion of the Right Achilles Tendon. This area was marked and
prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The five marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 1" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the tendon attachment.
Patient experienced a vagal response after the procedure and was awoken within seconds with a cool
towel and elevated legs. There was minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the muscle tendon junction of the Right Biceps Tendon. This area was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The three marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 2" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the tendon sheath.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the insertion of the Right MCL. These areas were marked and prepped
using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The 6 marked areas were first anesthetized using ~ 0.5cc blebs in a 1:1 mixture of 1% Lidocaine and
4.2% Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 27 cc of autologous blood
was obtained through venipuncture and processed using a Harvest SmartPReP2 system. The sites were
then injected using a 25G 2" needle and a total of 4cc of concentrated PRP. Approximatley 0.5-1 cc of
PRP was used for each injection along the ligament/tendon enthesis.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep
the bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 3-4 weeks
to re-evaluate. Patient was instructed to avoid anti-inflammatories and use Tylenol for pain as needed.
Patient is to avoid painfull activity. No lower limb stretching or impact exercise until re-evaluation.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Right prepatellar bursa was identified with mild effusion. The Injection
Site was marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. The site was then injected using a 25G 3" needle with
2cc of the Orthovisc Product. Patient tolereated the procedure well with minimal bleeding. The injection
site was bandaged and there were no obvious neuro or vascular deficits after the procedure. Patient was
told to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
1 week to re-evaluate, sooner if symptoms worsen. Patient was instructed to avoid anti-inflammatories
and use Tylenol for pain as needed.
Examination revealed mild swelling of the Left Index PIP. Stack splint was placed with finger in extension
at the PIP joint. Coban adhesive was used to secure the finger splint. Pt instructed on the importance
of keeping the finger in slight extension at all times with the splint on. Pt to follow up for bandage re-
taping as needed. Next appointment in 2 weeks, sooner if symptoms worsen.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Right Plantar Fascia attachment on the Calcaneous. This
area was marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 2-3 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 2" needle.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
coban adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
3-4 weeks to re-evaluate. Continue home stretches BID.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Left Plantar Fascia attachment on the Calcaneous. This
area was marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 2-3 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 2" needle.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
coban adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
3-4 weeks to re-evaluate. Continue home stretches BID.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Left Supraspinatus. The area below the acromiom was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was then anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 3-4 cc of a 1:1 mixture of
Kenalog-40 and 1% Lidocaine was injected using a 25G 2" needle. US was used to identify the joint
space and for needle guidance.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with an adhesive pad.
There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the
bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 1 weeks
to re-evaluate and continued treatment of upper neck/back pain. Continue home stretches BID.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 2-3 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 2" needle.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
coban adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
2 weeks to re-evaluate, soner if symptoms worsen. Continue with chopat bracing.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Right 1st MTP Joint. This area was marked and prepped
using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 1-2 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 2" needle.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with tefla padding and
coban adhesive. There were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
1 week to re-evaluate. Continue home stretches BID.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Coumadin INR discussed as well as risks and benefits of being on this medication during the procedure.
The area of pain was localized to the Right SI Joint. This area was marked and prepped using sterile
technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 5 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 4" needle under Ultrasound Guidance with a Curvilinear Probe
and an Superior approach.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the Left Supraspinatus. The area below the acromiom was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was then anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 3-4 cc of a 1:1 mixture of
Kenalog-40 and 1% Lidocaine was injected using a 25G 2" needle.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with an adhesive pad.
There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the
bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 1 weeks
to re-evaluate and continued treatment of upper neck/back pain. Continue home stretches BID.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the origin of the ATF and Ankle Joint. The Left Anterior Joint Recess was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was then anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 3-4 cc of a 1:1 mixture of
Kenalog-40 and 1% Lidocaine was injected using a 25G 2" needle. US was used to identify the joint
space, neurovascular structures, and for needle guidance.
Patient tolereated the procedure well with minimal bleeding. Area was bandaged with an adhesive pad.
There were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the
bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in 2 days to
re-evaluate and continued treatment of upper neck/back pain. Continue home stretches BID.
Steroid Trigger Finger Injection Procedure Note
- Risks and benefits of injection explained and discussed.
- Would like to move ahead with injection today.
PROCEDURE NOTE: Ultrasound Guided Corticosteroid Injection -Right Middle Finger Flexor Tendon
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Right middle finger flexor tendon was identified. The injection site was
marked and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then injected using a 27G 1" needle
with 1 cc of the Corticosteroid Injection - Rt. middle finger Flexor Tendon.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Laceration on the distal dorsal aspect of the Left INdex Finger was prepped in a sterile manner with
Hibaclense and Etoh x 3. Anesthesia was administered using ~2cc of 1% Lidocaine and a 27G 0.5 inch
needle. Five interupted sutures of 6.0 Prolene were placed in a sterile environment. Patient tolereated
the procedure well and the bleeding was controlled with sutures. The area was bandaged with tefla pad
and cobane. Patient was told to keep bandage on for the remainder of the day and follow up if there are
signs of infection or continued bleeding. Told to keep convered during the day with topical antibiotics
and air dry at night. Patient agreed to the plan and is to follow up in 7-10 days for suture removal,
sooner if symptoms worsen.
Written consent was obtained and the Risks and Benifits of the procedure were explained. The patient
agreed to have the procedure done today. Trigger points were marked in the area of the Left Upper
Trapezius 5 points. The area was prepped in sterile manner with Hibaclense and 70% Isopropyl Alcohol
x 3. A 1:1 mixture of 1% lidocaine and 4.2% Sodium Bicarbonate was injected with 27G 1/2" needle ~
0.5 cc into each lesion for a total of 2.5 cc. Patient tolerated the procedure well with minimal bleeding.
Area was cleaned and bandages. Pt denied any breathing difficulties and signs to call and return were
discussed. Pt felt relief of the area after injection therapy.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Left anterior lateral cyst measuring ~ 2 cm x 2 cm in diameter was
visualized under Ultrasound. The aspiration/injection site was marked and prepped using sterile technique
with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then aspirated with ~ 35 cc of
bloody fluid.
Patient tolereated the procedure well with minimal bleeding. The apsiration site was bandaged and
there were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the
bandage on for the remainder of the day and follow up if there are signs of infection, continued
bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up after MRI
complete to re-evaluate, sooner if symptoms worsen. Patient was instructed to call if she experienced
any problems before then and that there was a physician on call after hours if needed.
Date: 7/7/14
History: Left Elbow Swelling x 4 days. Pt reports hurting his elbow while doing carpentry work. Was
placed in abx 3 days ago, not improving.
Procedure was explained to the patient and questions were answered and risk/benefits discussed. Pt
signed consent to continue with procedure.
Area was marked under Ultrasound using a 12L probe. The Left olecranon bursa was identified and
needle insertion point marked on the superiormedial aspect of the elbow. Area was cleaned with
Hibaclense and Etoh x3. An 18G 2 inch needle on a 60 cc syringe was used to aspirate the fluid under
ultrasound guidance. Fluid appeared innocluated and 15 cc were obtain which was straw colored. Pt
tolerated the procedure and is to follow up in 1 day for re-evaluation and begin antibiotics.
Date: 5/16/14
History:Right Knee Cyst x 4 days. History of soft tissue contusion and fasciotomy.
Procedure was explained to the patient and questions were answered and risk/benefits discussed. Pt
signed consent to continue with procedure.
Area was marked under Ultrasound using a 12L probe. The Right suprapatellar bursa was identified and
needle insertion point marked on the superior lateral aspect of the knee. Area was cleaned with
Hibaclense and Etoh x3. An 18G 2 inch needle on a 60 cc syringe was used to aspirate the fluid under
ultrasound guidance. Fluid appeared serosanguinous and 10 cc were obtain. Fluid sent to lab for
aspiration. Pt tolerated the procedure and is to follow up at home with PCP.
US Hamstring
ULTRASOUND : Right Hamstring
Date: 1/1/18
History: Right hamstring pain x ~ 1 month. Has improved, but remains painfull when running.
Treatment with heat and NSAIDs.
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There was
no fluid detected near the site of pain. There was a 1.5 cm void seen on ultrasound in the middle 1/3 of
the lateral aspect of the biceps femoris, suggestive of a small longitudinal tear.
Date: 5/7/14
History:Right Knee Pain x 4 days. Pt reports hurting his knee while jumping and landing sideways while
running an obstacle race. Felt Left medial knee pain after incident. Able to wt bear without difficulty.
Wearing Hinged Ligament knee brace for comfort.
Procedure was explained to the patient and questions were answered and risk/benefits discussed. Pt
signed consent to continue with procedure.
Area was marked under Ultrasound using a 12L probe. The Right suprapatellar bursa was identified and
needle insertion point marked on the superior lateral aspect of the knee. Area was cleaned with
Hibaclense and Etoh x3. An 18G 2 inch needle on a 60 cc syringe was used to aspirate the fluid under
ultrasound guidance. Fluid appeared innocluated and only 1-2 cc were obtain which was bloody. Pt
tolerated the procedure and is to follow up in 1-2 weeks for re-evaluation
Date: 2/1/13
History:Left Knee Pain x 1 day. Pt reports hurting his knee while sliding into first base during practice.
Felt Left medial knee pain after incident. Reports h/o of ACL repair in highschool on same knee. Able to
wt bear without difficulty. Wearing Hinged Ligament knee brace for comfort.
Site: Left Knee
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There was
small joint effusion noted in the L suprepatellar recess. There was a 1.5 cm void seen on ultrasound in
the middle 1/3 of the Left MCL suggestive of a small longitudinal tear seen in the long axis view small
longitudinal tear. Trasverse view showed further tissue void without evidence of a full thickness tear.
LCL, Quadriceps tendon, and Patella tendon appear intact. No evidence of a popliteal cyst and hamstring
insertion appears normal. Recommend MRI for further evaluation of meniscus with MCL involvement.
Date: 1/16/14
History: Left foot pain x ~ 3 days. Painfull when running. Treatment with heat and NSAIDs.
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There was
trace fluid detected near the site of pain, base of 5th metatarsal. There was a 1.0 cm void seen on
ultrasound in the distal left peroneous brevis tendon, suggestive of a small longitudinal tear. Corticol
bone at abse of 5th appears intact.
Date: 4/14/14
History: Left foot pain x ~ 15 days secondary to twisting injury while playing soccer.
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There was
trace fluid detected near the site of pain, Left ATF. There was a 1.0 cm void seen on ultrasound in the
inferior back of the ATF, suggestive of a small horizontal tear. CFL appears intact. No cortical irregularity
seen on the Talar Dome. No joint fluid seen in the anterior recess.
IMPRESSION:
Date: 4/17/14
Patient Name:
Date: 4/17/14
Patient Name:
Area was examined using at 12L linear probe in both the Longitudinal and Transverse planes. There is a
focal anechoic trear of the proximal aspect of the right long head of the biceps tendon measuring 0.5 cm
short axis by 1.0 cm long axis along with a small joint effusion distending the biceps brachii tendon
sheath and mild distension of the subacromial-subdeltoid bursa. There is no involvement of hte short
head of the biceps tendon. The supraspinatus, subscapularis, and infraspinatus, and rotator cuff interval
appear normal. A moderate amount of infraspinatus and supraspinatus fatty degeneration is present.
Mild osteoarthrits of the acromioclavicluar joint. Additional focused evaluation at the sited of maximal
symptoms was unrevealing.
IMPRESSION: Focal incomplete partial-thickness tear of the right proximal biceps tendon with
infraspinatus and supraspinatus muscle atrophy.
Written consent was obtained after the risks, benefits, and questions were explained and answered. The
area of pain was localized to the Right Hip Joint. This area was marked and prepped using sterile
technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 4 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 3" needle under Ultrasound Guidance with a Curvilinea Probe and
an Anterior approach. The Femoral Nerve, Artery and Vein were visualized prior to needle insertion.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Left Supra-patellar space was identified. The injection site was marked
and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x3.
The marked area was anesthetized using a 0.5cc bleb in a 1:1 mixture of 1% Lidocaine and 4.2% Sodium
Bicarbonate solution on a 27G 0.5 inch needle. Approximatley 4 cc of a 1:1 mixture of Kenalog-40 and
1% Lidocaine was injected using a 25G 3" needle under Ultrasound Guidance using a Left Lateral
Suprapatellar approach. Patient tolereated the procedure well with minimal bleeding. The injection site
was bandaged and there were no obvious neuro or vascular deficits after the procedure. Patient was told
to keep the bandage on for the remainder of the day and follow up if there are signs of infection,
continued bleeding, or any other concerning problems. Patient agreed to the plan and is to follow up in
1 week to re-evaluate, sooner if symptoms worsen. Patient was instructed to call if she experienced any
problems before then and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the2nd toe MCP joint space was identified. The injection site was marked and
prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then injected using a 27G 1" needle
with 1 cc of the Corticosteroid Injection - Left 2nd toe MTP joint.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.
Written consent was obtained after the risks, benefits, and questions were explained and answered.
Under ultrasound guidance the Right subacromial bursae was identified. The injection site was marked
and prepped using sterile technique with Hibaclence and 70% Isopropyl Alchohol x 3.
The marked injection site was anesthetized using ~ 2cc blebs in a 1:1 mixture of 1% Lidocaine and 4.2%
Sodium Bicarbonate solution on a 27G 0.5 inch needle. The site was then injected using a 25G 2" needle
with 2 cc of the Corticosteroid and 2 cc of 1% Lidocaine.
Patient tolereated the procedure well with minimal bleeding. The injection site was bandaged and there
were no obvious neuro or vascular deficits after the procedure. Patient was told to keep the bandage on
for the remainder of the day and follow up if there are signs of infection, continued bleeding, or any
other concerning problems. Patient agreed to the plan and is to follow up in 1 week to re-evaluate,
sooner if symptoms worsen. Patient was instructed to call if she experienced any problems before then
and that there was a physician on call after hours if needed.